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The hepatic uptake of 99m Tc-mebrofenin and ICG is considered similar to the uptake of organic anions such as bilirubin and bile acids. Little is known about hepatic uptake mechanisms of both compounds and recent evidence suggests that the hepatic transporters for ICG and 99m Tc-mebrofenin are distinct.
The aim of this study was to identify the specific human hepatic transporters of 99m Tc-mebrofenin and ICG.
Methods: The uptake of 99m Tc-mebrofenin was investigated in cRNA-injected X. laevis oocytes expressing human OATP1B1, OATP1B3, OATP2B1, or NTCP. Chinese hamster ovary (CHO) cells stably expressing OATP1B1, OATP1B3, OATP2B1, or NTCP were used as a mammalian expression system. ICG transport into CHO cells was additionally imaged with confocal microscopy.
Results: We demonstrated that OATP1B1 and OATP1B3 are involved in the transport of 99m Tcmebrofenin. OATP1B1 showed an approximately 1.5-fold higher affinity for 99m Tc-mebrofenin compared to OATP1B3. ICG is transported by OATP1B3 and NTCP.
Conclusion: The transporter specificity of 99m Tc-mebrofenin and ICG partially overlaps as both compounds are transported by OATP1B3. 99m Tc-mebrofenin is also taken up by OATP1B1, whereas ICG is additionally transported by NTCP.
Introduction
Preoperative evaluation of future remnant liver function is crucial in order to select patients with an increased risk for postoperative liver failure before major liver surgery or living donor liver transplantation. The indocyanine green (ICG) clearance test and technetium-99m ( 99m Tc)-mebrofenin hepatobiliary scintigraphy (HBS) are valuable quantitative dynamic liver function tests used for the assessment of liver function before and after liver surgery(1-3).
99m Tc-mebrofenin is a 99m Tc-labeled iminodiacetic (IDA) derivate originally used for the diagnosis of a multitude of biliary diseases(4) and since recently for the assessment of liver function (1) . ICG is a tricarbocyanine dye that was first introduced to measure blood flow and later recognized as a useful compound for liver function testing (5) . 99m Tc-mebrofenin and ICG, both organic anions, are almost exclusively taken up by the liver and rapidly excreted into the bile without undergoing biotransformation and with no enterohepatic circulation (1, 6) . Although a similar hepatocellular uptake mechanism has been postulated, we recently demonstrated a significant difference between ICG and 99m Tc-mebrofenin uptake profiles in a rat model of hepatic ischemiareperfusion injury(7), suggesting that the specific hepatic transporters for ICG and 99m Tc-mebrofenin are distinct. The mechanisms underlying hepatocellular uptake of either compound have not yet been completely elucidated.
The hepatic clearance of numerous organic anions, including drugs and xenobiotics, is mainly facilitated by the Na + -independent uptake by organic anion transporting polypeptides (OATPs) (8, 9) and organic anion transporters (OATs) (10) . In human hepatocytes, OATP1B1, OATP1B3, and OATP2B1 isoforms are expressed at the basolateral plasma membrane of hepatocytes. In addition to
OATs and OATPs, human Na + -taurocholate co-transporting polypeptide (NTCP), which constitutes the main uptake system for bile acids, has been shown to also transport some drugs in a Na + -dependent manner (11) . The uptake of 99m Tc-mebrofenin and ICG by any of these transporters is therefore probable. This is supported by the fact that bilirubin, sulfobromophthalein (BSP), and bile salts, which are OATP (12) and NTCP (13) substrates, inhibit the uptake of 99m Tc-IDA agents (14, 15) , suggesting that a common transport mechanism exists for these compounds and 99m Tc-mebrofenin. Indirect evidence further suggests that ICG uptake is mediated by members of the OATP family, which is mainly based on the observation that ICG has the ability to inhibit the uptake of different OATP substrates(12). 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62   From a clinical perspective, an understanding of the hepatic uptake mechanisms of  99m Tcmebrofenin and ICG is necessary for proper interpretation of both liver function tests under various conditions of liver disease. The aim of this study was therefore to identify the specific human hepatocellular transporters of 99m Tc-mebrofenin and ICG. We hypothesized that specific members of the human OATP family or NTCP are involved in the uptake of both substances and that the specific transporters for 99m Tc-mebrofenin and ICG are, at least in part, distinct. While our experiments were ongoing, a report was published that identified OATP1B1 and OATP1B3 as specific 99m Tc-mebrofenin transporters (16) . 
Materials and Methods

Materials
MO)
Cell Lines Chinese hamster ovary (CHO) cell lines stably expressing human OATP1B1, OATP1B3, and OATP2B1 have been described (17, 18) . CHO wild type (CHO-WT) cells were used as control.
Flp-In CHO cells stably expressing human NTCP were generated by ligating the coding sequence of NTCP into pcDNA5/FRT (Invitrogen, Carlsbad, CA) as described previously (19) . Control cells were transfected with the empty pcDNA5/FRT vector (CHO-pcDNA5/FRT).
Cell Culture CHO-WT cells were cultured in Dulbecco's modified Eagle's medium (DMEM)
containing 10% fetal bovine serum, 50mM L-proline, and 100U/mL penicillin/streptomycin. The OATP1B1-, OATP1B3-, and OATP2B1-transfected CHO-cells were grown in DMEM containing 10%
fetal calf serum, 0.05mg/mL L-proline, 100U/mL penicillin/streptomycin, and 500Pg/mL geneticin G- (17, 18) . Flp-In CHO cells (pcDNA5/FRT and NTCP) were grown in HAM F-12 medium containing 10% fetal calf serum, 1mM L-glutamine, 100U/mL penicillin/streptomycin, and 500Pg/mL hygromycin B. Cells were incubated at 37°C in an atmosphere containing 5% CO 2 and 95% humidity. For transport experiments, cells were seeded on 3.5-cm dishes. Transport experiments were performed 3-4d after seeding after confluence had been reached. To enhance the expression of the recombinant proteins, cells were induced with 5mM sodium butyrate 24h before the transport experiment.
99m
Tc-Mebrofenin Uptake in X. laevis Oocytes X. laevis ooctes were prepared as described before (20) . In brief, 30 healthy oocytes were injected with 50nL of water or with 5ng of cRNA encoding human OATP1B1, OATP1B3, OATP2B1(21), or NTCP (22) were performed in OATP-expressing CHO cells and NTCP-expressing Flp-In CHO cells as described before (17, 20) . Briefly, cells were washed 3× with pre-warmed (37°C) sodium buffer or choline buffer.
The uptake of 99m Tc-mebrofenin in sodium or choline buffer was assayed at various predefined 99m Tcmebrofenin concentrations in a 1-mL final volume. After incubation for 0-2min, the cells were washed 4× with 2mL of ice-cold choline buffer and lysed with 1mL of 1% Triton-X100 (Fluka, Buchs, Switzerland) in PBS. A 500-μL aliquot was used for liquid scintillation counting. Protein concentrations were determined with the BCA assay (Thermo Fisher Scientific, Waltham, MA) using bovine serum albumin (BSA) as standard.
Kinetic analysis for the uptake of Tc-mebrofenin was performed for a 0.25-5mM substrate concentration range. Cellular uptake rates were determined after normalization for incubation time and total protein content. Net uptake rates by OATPs and NTCP were calculated as the difference in the uptake rate of the transporter and controls, namely CHO-WT and CHO-pcDNA5/FRT, respectively, for each concentration. Kinetic parameters, K m and V max , were determined with nonlinear regression analysis using the Michaelis-Menten equation . 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62 Transport experiments with ICG were performed as described above with the modification that, after incubation (0-5min) in ICG-containing sodium or choline buffer (0-200μM), cells were washed 4× with 2mL of ice-cold choline buffer containing 1% BSA followed by 4× washing with 2mL of ice-cold choline buffer. The cells were subsequently lysed with 300μL of 1% Triton-X100 in PBS. ICG concentrations were determined spectrophotometrically (Varioskan Flash, Thermo Fisher Scientific) at 805nm with the use of a standard curve.
To confirm the antagonistic effect of ICG (ranging from 0-100μM) on OATP-mediated values were determined by plotting the log inhibitor concentration against the net uptake rate with nonlinear regression of the data set.
Confocal Laser Scanning Microscopy (CLSM) CHO cells were grown on glass cover slips (Ø=25mm, Menzel-Gläzer, Braunschweig, Germany) for 3d until 50-60% confluence was reached.
Cells were induced with 5mM sodium butyrate 24h before CLSM. The cells were washed 3× with prewarmed (37°C) sodium buffer and incubated with 1mL of ICG solution for 0, 2, or 5min. The cells were subsequently washed 4× with 2mL of ice-cold choline buffer containing 1% BSA, followed by 4×
washing with ice-cold choline buffer. Cells were labeled with 1μM of carboxyfluorescein succinimidyl ester (CFSE, Invitrogen) for 5min, followed by 3× washing with ice-cold choline buffer. The cell nucleus was stained by incubating the cells with 0.01mg/mL 4',6-diamidino-2-phenylindole (DAPI, Invitrogen) for 10min, followed by 3× washing with ice-cold choline buffer. Cells were incubated for 2min with propidium iodide (PI) to confirm cell integrity.
CLSM was performed with an LSM 510 NLO confocal microscope (Carl Zeiss, Jena, Germany). Glass cover slips containing the cells were mounted in a metal ring system that was fitted in the temperature-controlled (37°C) translator stage of the microscope. PBS (1mL) was applied on the glass cover slip to prevent desiccation. ICG was excited with the 632.8-nm HeNe laser line and imaged through a 650-nm long pass emission filter. The 488-nm argon laser line was used in combination with a 525±25-nm band pass emission filter to visualize CFSE. DAPI was visualized in two-photon excitation mode using an 800-nm Ti:sapphire laser with a 425±35-nm band pass emission filter. PI was excited at 543nm and visualised using a 590±25-nm band pass emission filter.
Results
Transport of 99m
Tc-Mebrofenin in X. laevis Oocytes The uptake of 99m Tc-mebrofenin (25μM) was first investigated in cRNA-injected X. laevis oocytes expressing human OATP1B1, OATP1B3, OATP2B1, or NTCP. As shown in Fig. 1 , OATP1B1 and OATP1B3 transported 99m Tc-mebrofenin whereas no transport was observed in OATP2B1 and NTCP. Uptake into control (water-injected) oocytes was negligible, indicating that no endogenous transport or diffusion of 99m Tc-mebrofenin took place across the oocyte membrane.
Uptake of 99m
Tc-Mebrofenin by Transfected CHO Cells To exclude effects of the heterologous amphibian expression system on substrate specificity, transport experiments were repeated in a mammalian expression system. The OATP1B1-and OATP1B3-mediated transport of 99m Tcmebrofenin was confirmed in OATP-expressing CHO cells (Fig. 2) . At a concentration of 25µM, the uptake of 99m Tc-mebrofenin into the OATP1B1-transfected cells was enhanced by more than 30-fold vs. uptake into CHO-WT cells (P<0.05), whereas the uptake by OATP1B3 was enhanced more than 20-fold compared to the CHO-WT cells (P<0.05). Negligible transport was seen in the CHO-WT, OATP2B1-, and NTCP-transfected cells. Therefore, different expression systems do not affect the substrate specificity of the investigated transporters.
Next, we investigated the time-dependence of 99m Tc-mebrofenin (100µM) uptake into CHO cells expressing OATP1B1 and OATP1B3. The uptake of 99m Tc-mebrofenin by OATP1B1 (Fig. 3A) and OATP1B3 (Fig. 3B ) was linear up to 40 and 60s, respectively. The kinetic experiments were therefore performed using a 40-s incubation time. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62 following Michaelis-Menten constants (K m ) with associated maximum transport rates (V max ) were calculated (derived from 3 independent experiments for each transporter): OATP1B1: K m =1.68±0.29 mM, (V max =386nmol/mg protein/min) and OATP1B3: K m =2.57±0.85mM, (V max = 372nmol/mg protein/min). OATP1B1 exhibited a slightly higher affinity for 99m Tc-mebrofenin than OATP1B3 with similar maximal transport rates.
To correct for unknown transporter expression levels and to obtain an idea on individual transporter efficiency, the intrinsic clearance (V max /K m ) was calculated. OATP1B1 had a 1.5-fold higher intrinsic clearance compared to OATP1B3 (0.23 vs. 0.14μL/min/μg protein).
Uptake of ICG by
Transfected CHO Cells CLSM demonstrated that OATP1B3 and NTCP were able to transport ICG (Fig. 5A, B) . ICG was also taken up at low amounts by the CHO-WT cells as well as by OATP1B1, OATP2B1, and CHO-pcDNA5/FRT cells, which is suggested by the relatively low fluorescence intensity in the cytoplasm and the higher fluorescence intensity in perinuclear granules/vesicles (Fig. 6) . In OATP1B3-and NTCP-transfected cells, the cytoplasmic ICG fluorescence was considerably higher (Fig. 5A, B ) than in CHO-WT cells and cells expressing the other OATP isoforms. The absence of PI staining confirmed that the cells remained intact during the experiment (data not shown).
Next, the extent of ICG uptake by OATPs and NTCP was quantified spectrophotometrically in transfected CHO cells (Fig. 7A, B) . At a concentration of 50µM, the uptake of ICG after 1-min incubation increased twofold in OATP1B1-transfected cells compared to the CHO-WT cells.
Considerable background fluorescence was observed in the CHO-WT samples that was attributable to ICG adhering to the culture dish (not shown). OATP1B1-and OATP2B1-transfected cells exhibited a similar uptake to CHO-WT cells. The abovementioned background fluorescence made it difficult to determine transporter-specific kinetic parameters for ICG, as a result of which these data are not presented. The ICG uptake by NTCP-transfected Flp-In CHO cells was enhanced threefold after 1-min incubation compared to control (CHO-pcDNA5/FRT cells). The uptake of ICG by NTCP was significantly reduced when incubated in the absence of Na + , providing corroborative evidence for the involvement of NTCP in the Na + -dependent transport of ICG.
Inhibition of OATP-Mediated Transport by ICG Earlier studies had demonstrated that ICG is an
inhibitor of OATP-mediated transport (21, 24 Studies on the uptake of IDA derivates in cultured rat hepatocytes have evinced that IDA uptake is Na + -independent, temperature-and pH-dependent, and reduced in the presence of increasing bilirubin concentrations (15, 14) . In addition, BSP, taurocholate, ICG, and Rose Bengal have been implicated as inhibitors of IDA uptake (14, 15) , whereby the antagonistic effect of these compounds is highly dependent on the structure of the IDA agent. For instance, of all IDA agents, 99m Tc-mebrofenin uptake is inhibited the least by bilirubin (14) . Based on these findings it was concluded that, at least in part, the uptake of IDA derivates was similar to the uptake mechanism of bilirubin and BSP(4). A possible involvement of OATPs in the uptake of IDA derivates became evident after Jacquemin et al. (23) found that BSP and TC are taken up by OATP. The specific involvement of the OATP1B1 and OATP1B3 isoforms in the uptake of 99m Tc-mebrofenin has recently been confirmed (16) , but the possible role of the OATP2B1 isoform and NTCP were not considered and no kinetics were calculated.
Our transport experiments in cRNA-injected X. laevis oocytes and transfected CHO cells corroborated that 99m Tc-mebrofenin is transported by OATP1B1 and OATP1B3 and showed that OATP2B1 and NTCP are not involved in the uptake of 99m Tc-mebrofenin. OATP1B1 exhibited an approximately 1.5-fold higher affinity and intrinsic clearance (V max /K m ) for 99m Tc-mebrofenin compared to OATP1B3, suggesting that OATP1B1 may be the preferential transporter for 99m Tc-mebrofenin.
Although the mM-range of K m implies a relatively low affinity for 99m Tc-mebrofenin in comparison to 49  50  51  52  53  54  55  56  57  58  59  60  61  62 other OATP1B1 and OATP1B3 substrates (18, 24) , the intrinsic transport capacities (V max /K m ) of OATP1B1 and OATP1B3 indicate that the transport of 99m Tc-mebrofenin is highly effective.
Similarly, indirect evidence that ICG is transported by members of the organic OATP family is mainly based on the observation that ICG is a well-known inhibitor of OATP-mediated transport(12).
Our study confirmed that ICG is a potent inhibitor of all investigated OATP isoforms and of NTCP. We also demonstrated that only OATP1B3 and NTCP are involved in uptake of ICG, clearly indicating that the capacity of a compound to inhibit OATP-mediated transport does not necessarily coincide with its uptake by the respective OATP isoform, as was shown previously for drugs (17) . Hepatic ICG and 99m Tc-mebrofenin uptake are impaired in cholestatic patients. OATPs have been implicated in the uptake of bilirubin (12), which might explain the competitive inhibition of 99m Tcmebrofenin by high bilirubin concentrations (14) . Nevertheless, the involvement of OATP1B1 and OATP1B3 in the uptake of bilirubin is controversial. Transport of bilirubin by OATP1B1 and OATP1B3
has been demonstrated in cRNA-injected X. laevis oocytes, in which bilirubin uptake was significantly less efficient in OATP1B3 compared to OATP1B1 (28) . Similarly, OATP1B1 but not OATP1B3 was able to transport bilirubin in stably transfected human embryonic kidney cells (HEK293) (12) .
Contrastingly, Wang et al. (29) precluded a physiological role for OATP1B1 in bilirubin transport.
Therefore, the specific effect and exact mechanism of bilirubin on OATP-mediated transport remains elusive and warrants closer investigation. Besides increased plasma bilirubin levels, conjugated bile acids accumulate in plasma during cholestasis. Conjugated bile acids are predominantly transported by NTCP and it is therefore probable that bile salts inhibit the NTCP-mediated uptake of ICG during cholestasis. In addition, downregulation of uptake transporters during cholestasis may contribute to the 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61 Tc-mebrofenin decreases with the severity of liver steatosis (39) .
Furthermore, the abovementioned cytokines play an important role in ischemia-reperfusion injury as well as liver regeneration. We recently compared the ICG clearance test with 99m Tc-mebrofenin HBS in rats after ischemia-reperfusion injury combined with a partial hepatectomy(7) and during liver regeneration after major hepatectomy (40) . In both models a differential decrease in OATP isoforms was observed, contributing to the difference in hepatic uptake between ICG and 99m Tc-mebrofenin after ischemia-reperfusion injury and during regeneration.
In the final analysis, under normal conditions ICG and 99m Tc-mebrofenin are considered to have high hepatic extraction ratios. The total hepatic clearance from the blood is therefore rate-limited by blood flow. It is now evident that several key uptake transporters are downregulated during liver disease, affecting the transport capacity and hepatic extraction. Hence the ICG clearance test and 99m Tc-mebrofenin HBS monitor not only blood flow but also the transport capacity. Given the high extraction of both compounds, it is likely that not the basolateral uptake systems but the canalicular export systems will become the clearance determining transporters under pathophysiological conditions (41) .Despite the relatively underexplored dynamics of blood flow and transport capacity under various pathophysiological conditions, the uptake and intracellular transit of 99m Tc-mebrofenin and ICG represent clinically relevant hepatic function parameters insofar as their transport is similar to various endogenous and exogenous substances such as bilirubin, bile acids, hormones, drugs, and toxins, whose uptake also relies on blood flow (31, 41) .
Conclusion
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Legends
